Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
06/2004
06/03/2004WO2004046090A2 Aryl ureido derivatives and their medical use
06/03/2004WO2004046066A1 Method for deuteration or tritiation of heterocyclic ring
06/03/2004WO2004045607A1 Novel hydroxyindoles, use as inhibitors of phosphodiesterase 4 and method for production thereof
06/03/2004WO2004045597A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
06/03/2004WO2004045536A2 Method and compositions for temporarily incapaciting subjets
06/03/2004WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/03/2004WO2004033418A3 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
06/03/2004WO2004026236A3 Cyclopentyl indole derivatives
06/03/2004WO2004002419A3 Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment
06/03/2004WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase
06/03/2004US20040106826 Process for synthesizing L--methylene glutamic acid and analogs
06/03/2004US20040106792 Biphenyl compound
06/03/2004US20040106669 inhibitor against type-X sPLA2 (secretary PLA2) as an active ingredient
06/03/2004US20040106630 Bicyclic protein kinase inhibitors
06/03/2004US20040106618 3-heteroarylidene-2-indolinone compounds useful in the prevention and treatment of protein kinase related cellular disorders such as cancer
06/03/2004US20040106606 Dihydropyrones with tethered heterocycles
06/03/2004US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent
06/03/2004US20040106597 Novel fused indazoles and indoles and their use for the treatment of glaucoma
06/03/2004US20040106560 such as N1-L-Arginylspermidine for protecting from damage from extended ischemic/hypoxic events
06/03/2004DE10253426A1 Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
06/03/2004DE10252665A1 4-Aminomethyl-1-aryl-cyclohexylamin-Derivate 4-aminomethyl-1-aryl-cyclohexylamine derivatives
06/03/2004CA2506735A1 Indole derivatives as somatostatin agonists or antagonists
06/03/2004CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication
06/03/2004CA2506232A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
06/03/2004CA2506112A1 Substituted aralkyl derivatives
06/03/2004CA2506010A1 A method for deuteration of a heterocyclic ring
06/03/2004CA2505988A1 Novel hydroxyindoles, use as inhibitors of phosphodiesterase 4 and method for production thereof
06/03/2004CA2503316A1 Method and compositions for temporarily incapacitating subjects
06/03/2004CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/03/2004CA2502705A1 Aryl ureido derivatives and their medical use
06/02/2004EP1424335A1 Indole derivatives
06/02/2004EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
06/02/2004EP1423393A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
06/02/2004EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors
06/02/2004EP1423365A1 Process for the preparation of indole derivatives
06/02/2004EP1423363A1 Oral antidiabetic agents
06/02/2004EP1423356A2 Novel aminobenzoephenones
06/02/2004EP1423110A2 Cbi analogues of cc-1065 and the duocarmycins
06/02/2004EP1423006A1 Agonists and antagonists of 5h 3?-like receptors of invertebrate s as pesticides
06/02/2004CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
06/02/2004CN1501928A Small molecule compositions for binding to hsp90
06/02/2004CN1501914A Indoline derivative and process for producing the same
06/02/2004CN1500787A Cyclic nitrones and pharmaceutical compositions containing them
06/02/2004CN1500779A Cyclic nitrones and pharmaceutical compositions containing them
06/02/2004CN1500773A Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
06/02/2004CN1500769A Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds
06/02/2004CN1152040C Carbazole derivatives, preparing process thereof and pharmaceutical combination containing the same
06/01/2004US6743926 Process for the preparation of indole derivatives and intermediates of the process
06/01/2004US6743817 Substituted fused pyrroleimines and pyrazoleimines
06/01/2004US6743810 Indol-3-yl derivatives
06/01/2004US6743796 Psychological disorders; schizophrenia; parkinson's disease
06/01/2004US6743793 Dp receptor antagonist; prostaglandin d
06/01/2004US6743373 Reagent based on enantiopure amino acid in which amino group carries activating group to form active precursor of isocyanate group and carboxyl group is substituted; separation of enantiomers having free functional group
05/2004
05/27/2004WO2004043958A1 Fused heterocyclic compounds
05/27/2004WO2004043920A1 Polymorphs of bicifadine hydrochloride
05/27/2004WO2004043919A1 A process for the preparation of 3-and 4-aminophthalimide.
05/27/2004WO2004043909A1 Cyclohexylurea derivatives
05/27/2004WO2004043900A2 4-alkyl/4-alkenyl/4-alkynyl methyl/-1-arylcyclohexylamine derivatives
05/27/2004WO2004043899A1 4-aminomethyl-1-aryl-cyclohexylamine derivatives
05/27/2004WO2004043362A2 Acyl guanidine compounds and use thereof
05/27/2004WO2004043350A2 PURIFIED COMPOUNDS THAT INHIBIT INTRACELLULAR α4/PAXILLIN BINDING
05/27/2004WO2004043336A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases
05/27/2004WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
05/27/2004WO2003016276A3 3-substituted oxindole beta-3 agonists
05/27/2004US20040102646 Method of resolving optical isomers of amino acid derivative
05/27/2004US20040102638 Polymorphs of bicifadine hydrochloride
05/27/2004US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease
05/27/2004US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors
05/27/2004US20040102509 Kinase inhibitors for the treatment of disease
05/27/2004US20040102508 Naphathalene derivatives which bind to the ep4 receptor
05/27/2004US20040102507 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
05/27/2004US20040102491 Antimicrobial agents
05/27/2004US20040102467 Antiinflammatory agents; central nervous system disorders; antiproliferative agents
05/27/2004US20040102458 Antiproliferative agents; antitumor agents; binding to chaperone protein
05/27/2004US20040102442 Central nervous system disorders; brain disorders
05/27/2004US20040102437 Prevention cytokine migration; hypotensive agents; asthma therapy
05/27/2004US20040101523 Blocking biosynthesis of neurotransmitters; enzyme inhibitors; cardiovascular disorders
05/27/2004US20040100188 Anthracene derivative and organic electroluminescence device using the derivative
05/27/2004DE10253322A1 New 4-(alkyl, alkenyl or alkynyl)-cyclohexylamine derivatives, are ORL1 receptor ligands useful e.g. for treating anxiety, depression, epilepsy, senile dementia, withdrawal symptoms or especially pain
05/27/2004DE10252650A1 New 1,4-disubstituted cyclohexylamine derivatives, are opioid receptor like-receptor 1 receptor ligands useful e.g. for treating anxiety, depression, epilepsy, senile dementia, withdrawal symptoms or especially pain
05/27/2004CA2505372A1 Fused heterocyclic compounds
05/27/2004CA2505003A1 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases
05/27/2004CA2504732A1 Polymorphs of bicifadine hydrochloride
05/26/2004EP1422553A1 Improved base precursors for use in a photothermographic element
05/26/2004EP1421634A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
05/26/2004EP1421064A1 Process for the preparation of 3-spiro'cyclohexam-1,3'-'3h!indolin-2'-one! derivatives
05/26/2004EP1420781A2 Analgetic pyrroline derivatives
05/26/2004EP1420644A1 Substituted propargylamines
05/26/2004EP1027332B1 Novel lactam metalloprotease inhibitors
05/26/2004EP0874819B1 Imides as pde iii, pde iv and tnf inhibitors
05/26/2004CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods
05/26/2004CN1151161C Medicine nitrate salts
05/26/2004CN1151133C Anthranilic acid amides and use thereof as medicaments
05/26/2004CN1151129C 2-acryl-3-substituted indoacetamide derivative and its medical application
05/26/2004CN1151128C Process for preparing pineal hormone
05/26/2004CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
05/25/2004US6740754 Process to produce oxazolidinones
05/25/2004US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/25/2004US6740673 Quarternary ammonium compounds
05/25/2004US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)